Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The DTCPayer Disconnect Manufacturer coupons and direct purchasing programs are growing popular consumer options the Lilly Direct channel accounted for 45% of new prescription volume for obesity drugs in Q3 2025 for the injectable GLP-1 tirzepatide (Zepbound)
From the beginning of 2024 to mid-2025, Gallup found, the number of Americans using injectable weight-loss drugs increased from 5.8% to 12.4% What are they
NAC provides the cysteine your body needs to synthesize glutathione, while also offering unique respiratory and neurological benefits
The challenge is to get these results into clinical practice, to get the drug used by the people who will benefit from it, who will live longer without dialysis, without heart attacks, without strokes, if they take this drug. Conducted between June 2019 and May 2021, the trial saw half of all patients receiving a 1 mg dose of semaglutide each week, and half receiving a placebo
May 6, 2025
